News

ReCAP is a series of interviews with the members of the RBDCOV Community Advisory Panel that will explore the world of community engagement in EU projects and the importance of…

The Laboratory of Medical Microbiology at the University of Antwerp, Belgium, plays a crucial role in the NeoIPC project, acting as the central microbiology laboratory for its various studies. Recently, we had…

The ORCHESTRA project, “Connecting European Cohorts to Increase Common and Effective Response to SARS-CoV-2 Pandemic”, has officially concluded. This European research initiative brought together scientists from 37 different partner institutions from…

On 16th September, 2024 we kicked off the second edition of our online course, “Fungal Infections in Paediatrics” on our PentaTr@ining platform, with more than 200 delegates logging in from across the world. The innovative programme is run on our virtual learning environment, providing…

In healthcare, inclusivity is not just a moral imperative, it is also a strategic necessity for achieving widespread immunity to infections and diseases, like COVID-19, and advancing public health outcomes.…

Every year, on September 13th, we observe World Sepsis Day, an important date in the calendar to raise awareness about sepsis – a life-threatening condition that occurs when the body’s response…

Our early career researchers gathered at the PIM 2024 which provided a great opportunity for these young professionals to discuss collaboration opportunities, career development, exchange ideas and update each other on their career trajectories and ongoing projects. Here are…

Our 3-day PentaTr@ining Namibia 2024 residential course came to a close on July 4th 2024. The course was organised in partnership with several key stakeholders, including the Namibia HIV Clinicians…

Laurus Labs has submitted an application to the US Food and Drug Administration (FDA) for the tentative approval of paediatric Darunavir/ritonavir (pDRV/r (120/20 mg)). UNIVERSAL is the first product development…

Analytical treatment interruption (ATI) is a crucial component of HIV cure research, but discussions have largely focused on adult populations. A recent expert opinion from the EPIICAL consortium, published in…

We are thrilled to announce the release of the Action Plan “Accelerating bnAbs for Peri- and Post-Natal HIV Prophylaxis”. Developed by a Task Force of leading experts and stakeholders, including…

This World Hepatitis Day, with the theme “It’s Time for Action,” let’s turn our focus to underserved and often overlooked populations in the fight against this preventable disease, children and…

Arriving at the International Workshop on Pediatrics & HIV 2024, we felt a mix of nerves and excitement, knowing we were about to be surrounded by experts who spend their…

The PediCAP trial team is pleased to announce the successful completion of a series of dissemination meetings aimed at sharing trial results with key stakeholders in Mozambique. These meetings targeted…

A new collaborative project called SUPPORT has officially launched to train the next generation of researchers who will focus on preventing mortality among these children. The SUPPORT initiative, funded by…

From 14 to 16 May, 2024, PentaTr@ining in collaboration with UNICEF, the World Health Organization (WHO) and with support from the International Organization for Migration (IOM), brought together over 50…

The European Commission has granted a 15-month extension to the RBDCOV project, allowing researchers additional time to recruit volunteers for the HH-3 clinical trial. This trial assesses the efficacy, tolerability,…

Last week, the VERDI project team gathered in Tallinn, Estonia, and online for the 4th General Assembly. This year’s meeting, which brought together around 60 people from 30 partner institutions,…